Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease

  • Darby, David (Primary Chief Investigator (PCI))
  • Wilson-Lee, Phoebe (Project Manager)

Project: Research

Project Details

StatusFinished
Effective start/end date13/07/21 → 31/12/24

Keywords

  • Alzheimer's disease
  • Clinical trial